INVO Fertility, Inc. (IVF) Fair Value 2026

IVF · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.1 /10

32 fundamental signals · 2 models active

Value Trap Risk

WARN (52/100)

Quick Summary — As of 2026-08-28, INVO Fertility, Inc. (IVF) trades at $1.00, versus a $3.69 median fair value across its 2 active models — 268.6% above the current price. QOC: 5.1/10. Value Trap Risk: 52/100 (WARN). 2/13 models active.

Key Facts

Ticker
IVF
Price
$1.00
Quality Score
5.1/10
Value Trap Risk
52/100
Models Active
2/13
Last Updated
Strength: PWERM suggests +487.2% upside with 32% confidence
Risk: Value Trap score of 52 suggests caution despite apparent undervaluation

Is INVO Fertility, Inc. (IVF) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, INVO Fertility, Inc. (IVF) appears undervalued as of : the median of 2 independent fair value estimates is $3.69, 268.6% above the current price of $1.00. Estimates range from $1.50 to $5.87. IVF scores 5.1/10 on fundamental quality and 52/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. IVF’s +268.6% gap is wider than that market norm, and the Medical Devices sector median is -43.7%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy INVO Fertility, Inc. Stock in 2026? →

What Fair Value Does Each Model Give IVF?

2 Intrinsic Value Models vs. Current Price ($1.00)

Core Models (Unlocked)
Model Fair Value Upside
Option-Based · Medium Conviction
 $5.87 +487.2%
Relative · Low Conviction
 $1.50 +49.9%

All Models Active

All 2 models are displayed above.

What Is INVO Fertility, Inc. (IVF) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, INVO Fertility, Inc.'s intrinsic value is estimated at a median fair value of $3.69. At a current market price of $1.00, 2 of 2 active valuation models identify upside potential, projecting a median implied return of +268.6%. Notably, PWERM sees the most upside at +487.2% (fair value: $5.87), while Regime Cross is the most conservative at +49.9% ($1.50). The spread between these extremes — +437.3% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About IVF?

2 of 13 models are currently active for IVF. All 2 active models suggest the stock trades below fair value. Taken together, their median fair value for IVF is $3.69 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does IVF Rank in Medical Devices?

Among 159 Medical Devices stocks, IVF ranks #123 by Quality of Company score. CirclFi's QOC score of 5.1/10 evaluates 32 fundamental signals. A score of 5.1 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

As a healthcare company, INVO Fertility, Inc. operates in a sector where patent cliff exposure is a critical driver of valuation. Investors evaluating IVF should weigh these sector-specific dynamics alongside our model-derived fair values.

Is IVF a Value Trap?

CirclFi's Value Trap algorithm assigns IVF a score of 52/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for INVO Fertility, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, INVO Fertility, Inc. is rated at 5.1/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

The gap between the most bullish and bearish model spans +437.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every IVF valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across IVF's 2 active models, average confidence is 25%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy INVO Fertility, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

MDAISpectral AI, Inc.QOC 5.1VVOSVivos Therapeutics, Inc.QOC 5.0CATXPerspective Therapeutics, Inc.QOC 5.2VTAKCatheter Precision, Inc.QOC 5.0CTSOCytosorbents CorporationQOC 5.2TNONTenon Medical, Inc.QOC 5.0GMEDGlobus Medical, Inc.QOC 9.2IARTIntegra LifeSciences Holdings CorporationQOC 7.1NSPRInspireMD, Inc.QOC 6.1IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: MDAI · VVOS · CATX · VTAK · CTSO · TNON · GMED · IART · NSPR · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to IVF?

7 companies across all industries closest to IVF’s Quality of Company score of 5.1/10.

DMACDiaMedica Therapeutics Inc.QOC 5.1LGVNLongeveron Inc.QOC 5.1ROYLRoyale Energy, Inc.QOC 5.1GDTCCytoMed Therapeutics LimitedQOC 5.1IGCIGC Pharma, Inc.QOC 5.1IXHLIncannex Healthcare Inc.QOC 5.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: DMAC · LGVN · ROYL · GDTC · IGC · IXHL · NVDA

Where Does IVF Sit in CirclFi's Medical Devices Rankings?

IVF is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About INVO Fertility, Inc.’s Valuation?

What is INVO Fertility, Inc.'s intrinsic value in 2026?

CirclFi puts INVO Fertility, Inc. (IVF)'s intrinsic value at $3.69 — the median of 2 independent model estimates as of 2026-08-28, ranging from $1.50 to $5.87. The Quality of Company score is 5.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is IVF overvalued or undervalued right now?

At $1.00, 2 of 2 active models suggest IVF may be undervalued, while 0 indicate potential overvaluation. The median of all 2 fair value estimates is $3.69, 268.6% above the current price of $1.00 — a consensus view that IVF is undervalued. The assessment depends on which methodology best fits INVO Fertility, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 5.1 mean for IVF?

INVO Fertility, Inc.'s QOC of 5.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on IVF?

CirclFi analyzes IVF with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is IVF a value trap in 2026?

INVO Fertility, Inc.'s Value Trap score is 52/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, INVO Fertility, Inc. (IVF) has a median fair value of $3.69 — 268.6% above the current price of $1.00 — as of 2026-08-28.” Source: circlfi.com/stock/IVF/ · Methodology
Primary sources for this IVF valuation
  • Financial statements: INVO Fertility, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001417926) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for IVF as of ; valuations recomputed .